Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major Depression

Psychiatr Danub. 2022 Fall;34(3):533-534.
No abstract available

MeSH terms

  • Depression
  • Depressive Disorder, Major* / drug therapy
  • Humans
  • Paroxetine* / therapeutic use
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Vascular Endothelial Growth Factor A

Substances

  • Paroxetine
  • Vascular Endothelial Growth Factor A
  • Serotonin Uptake Inhibitors